The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca has ...
Drug companies are taking advantage of a global climate treaty to boost profits. The treaty, signed by some 120 countries nearly a decade ago, is now providing inhaler makers with a golden escape ...
Kindeva, a CDMO focused on drug delivery devices, hauled in a 33 million pound sterling ($42.1 million) grant from the U.K.’s Life Sciences Innovation Manufacturing Fund that will be used to bolster ...
The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could jeopardize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback